ストックスクリーナーアプリを入手
14.71
0.48%
-0.01
前日終値:
$14.70
開ける：
$14.95
24時間の取引高:
455.72K
Relative Volume:
0.27
時価総額：
$1.75B
収益：
-
当期純損益:
$-115.88M
株価収益率:
-9.51
EPS:
-1.5468
ネットキャッシュフロー:
$-104.72M
1週間 パフォーマンス:
-13.48%
1か月 パフォーマンス:
+17.04%
6か月 パフォーマンス:
-59.79%
1年 パフォーマンス:
-26.85%
1日の値動き範囲:
$14.51
$15.55
1週間の範囲:
$13.82
$16.91
52週間の値動き範囲:
$10.60
$38.12
Edgewise Therapeutics Inc Stock (EWTX) Company Profile
EWTX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
EWTX
Edgewise Therapeutics Inc
|
14.71 | 1.75B | 0 | -115.88M | -104.72M | -1.5468 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.62 | 128.25B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
532.29 | 63.70B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
547.82 | 39.07B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
251.82 | 33.82B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
231.98 | 27.58B | 3.81B | -644.79M | -669.77M | -6.24 |
Edgewise Therapeutics Inc Stock (EWTX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-04-30 | 開始されました | Guggenheim | Buy |
| 2025-04-02 | ダウングレード | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-07 | 開始されました | Scotiabank | Sector Outperform |
| 2025-01-22 | 開始されました | Stifel | Hold |
| 2024-11-22 | 開始されました | Evercore ISI | Outperform |
| 2024-03-07 | 開始されました | Piper Sandler | Overweight |
| 2023-05-01 | 開始されました | Truist | Buy |
| 2022-08-25 | ダウングレード | Goldman | Neutral → Sell |
| 2022-04-13 | 開始されました | RBC Capital Mkts | Outperform |
| 2022-01-28 | 開始されました | Goldman | Neutral |
すべてを表示
Edgewise Therapeutics Inc (EWTX) 最新ニュース
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares Sold by Deep Track Capital LP - MarketBeat
Edgewise Therapeutics Reports Strong Q1 2025 Progress - TipRanks
Wedbush Adjusts Price Target on Edgewise Therapeutics to $40 From $43, Maintains Outperform Rating - marketscreener.com
Edgewise Therapeutics shares fall on in-line Q1 results By Investing.com - Investing.com UK
EDGEWISE THERAPEUTICS Earnings Results: $EWTX Reports Quarterly Earnings - Nasdaq
Edgewise Therapeutics, Inc. SEC 10-Q Report - TradingView
Edgewise Therapeutics Reports First Quarter 2025 Financial Results and Recent Business Highlights - PR Newswire
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares Bought by Braidwell LP - MarketBeat
Bamco Inc. NY Takes Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Schonfeld Strategic Advisors LLC Reduces Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Edgewise Therapeutics Executives Sell Shares to Cover Tax Obligations - TradingView
Ally Bridge Group NY LLC Sells 104,519 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Acuta Capital Partners LLC Buys 24,658 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Invesco Ltd. Sells 21,341 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Edgewise Therapeutics (EWTX) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Baker BROS. Advisors LP Raises Stake in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares Acquired by Envestnet Asset Management Inc. - Defense World
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) is Novo Holdings A S's 4th Largest Position - MarketBeat
Marshall Wace LLP Has $798,000 Stock Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Edgewise Therapeutics (NASDAQ:EWTX) Now Covered by Guggenheim - MarketBeat
Voya Investment Management LLC Lowers Stock Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Is Edgewise Therapeutics, Inc. (EWTX) the Best Small Cap Stock to Buy with the Biggest Upside Potential? - Insider Monkey
Adage Capital Partners GP L.L.C. Purchases 218,491 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Foresite Capital Management VI LLC Buys New Stake in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Top 11 Small Cap Stocks to Buy with Biggest Upside Potential - Insider Monkey
First Light Asset Management LLC Purchases Shares of 780,639 Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Why Edgewise Therapeutics Stock Popped This Week - The Globe and Mail
Edgewise Therapeutics (EWTX) Initiated at Buy by Guggenheim, Pot - GuruFocus
Edgewise a new buy at Guggenheim on two pipeline prospects - Seeking Alpha
Edgewise Therapeutics (EWTX) Receives Positive Coverage with Str - GuruFocus
Guggenheim Starts Edgewise Therapeutics With Buy Rating, $41 Price Target - marketscreener.com
79,381 Shares in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Bought by Harvest Investment Services LLC - MarketBeat
JPMorgan Chase & Co. Sells 34,071 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Russell Investments Group Ltd. Makes New $883,000 Investment in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Analysts Set Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Price Target at $40.38 - MarketBeat
Edgewise Therapeutics (NASDAQ:EWTX) Earns "Outperform" Rating from Wedbush - MarketBeat
Is Edgewise Therapeutics Inc. (NASDAQ:EWTX) the Most Promising Small-Cap Stock According to Analysts? - Insider Monkey
Jump Financial LLC Sells 76,628 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares Sold by Walleye Capital LLC - MarketBeat
Edgewise Therapeutics Inc (EWTX) 財務データ
収益
当期純利益
現金流量
EPS
Edgewise Therapeutics Inc (EWTX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Russell Alan J | Chief Scientific Officer |
May 02 '25 |
Sale |
16.45 |
1,551 |
25,520 |
18,521 |
| MOORE JOHN R | General Counsel |
May 01 '25 |
Option Exercise |
0.00 |
5,209 |
0 |
8,461 |
| MOORE JOHN R | General Counsel |
May 02 '25 |
Sale |
16.45 |
1,930 |
31,757 |
6,531 |
| KOCH KEVIN | President and CEO |
May 01 '25 |
Option Exercise |
0.00 |
10,417 |
0 |
24,895 |
| KOCH KEVIN | President and CEO |
May 02 '25 |
Sale |
16.45 |
4,276 |
70,358 |
20,619 |
| Donovan Joanne M. | CMO |
May 01 '25 |
Option Exercise |
0.00 |
10,417 |
0 |
26,775 |
| Donovan Joanne M. | CMO |
May 02 '25 |
Sale |
16.45 |
5,187 |
85,348 |
21,588 |
| Derakhshan Behrad | Chief Business Officer |
May 01 '25 |
Option Exercise |
0.00 |
5,209 |
0 |
22,046 |
| Derakhshan Behrad | Chief Business Officer |
May 02 '25 |
Sale |
16.45 |
1,691 |
27,824 |
20,355 |
| Carruthers R Michael | Chief Financial Officer |
May 01 '25 |
Option Exercise |
0.00 |
5,209 |
0 |
82,328 |
2.11%
0.83%
大文字化:
|
ボリューム (24 時間):